PROVIDER PROFILE · NPI 1093949398

Amy SessionsPA

Physician AssistantDallas, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$4K

Peer benchmark

Total Medicare services vs. 6,198 Physician Assistant providers in TX — bottom quintile (cohort median 254).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$1K

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Sucralfate20 claims

Pantoprazole Sodium13 claims

QUALITY · MIPS · 2024

Final MIPS score

82.9

Quality

70.2

Cost

72.8

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.33%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 450044

Hospital

REFERRAL NETWORK

Where Amy Sessions's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 7 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Christopher Michael Neurosurgery · Dallas, TX	58	149
METDALSPI, LLC	28	71
Victor Ramon Anesthesiology · Dallas, TX	20	32
BAYLOR UNIVERSITY MEDICAL CENTER	19	29

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Christopher Michael Neurosurgery · Dallas, TX	75	249
BAYLOR UNIVERSITY MEDICAL CENTER	40	45
SMERUD, MICHAEL	31	45
DIRTING, JAMES	17	20
MURPHY, GERALD	16	19
Robert Fischer Internal Medicine · Dallas, TX	12	38
HURST, DAVID	11	18

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history